Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
| 1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
| 15359 | 1 | ANTI DRUG ANTIBODIES//BIOANALYSIS//LIGAND BINDING ASSAY | 743 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ANTI DRUG ANTIBODIES | authKW | 1580627 | 10% | 51% | 73 |
| 2 | BIOANALYSIS | journal | 1104391 | 26% | 13% | 195 |
| 3 | LIGAND BINDING ASSAY | authKW | 570954 | 5% | 38% | 35 |
| 4 | ANTIDRUG ANTIBODIES | authKW | 374425 | 2% | 55% | 16 |
| 5 | ANTI DRUG ANTIBODY ADA | authKW | 312340 | 1% | 82% | 9 |
| 6 | IMMUNOGENICITY | authKW | 278392 | 20% | 4% | 148 |
| 7 | DRUG INTERFERENCE | authKW | 247174 | 2% | 45% | 13 |
| 8 | GYROLAB | authKW | 246785 | 1% | 73% | 8 |
| 9 | NAB ASSAY | authKW | 176736 | 1% | 83% | 5 |
| 10 | SERUM BASED BIOASSAY | authKW | 169668 | 1% | 100% | 4 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Biochemical Research Methods | 10978 | 40% | 0% | 300 |
| 2 | Chemistry, Analytical | 5352 | 37% | 0% | 273 |
| 3 | Rheumatology | 2565 | 11% | 0% | 81 |
| 4 | Pharmacology & Pharmacy | 1746 | 29% | 0% | 219 |
| 5 | Immunology | 978 | 19% | 0% | 138 |
| 6 | Medical Laboratory Technology | 221 | 3% | 0% | 23 |
| 7 | Toxicology | 130 | 5% | 0% | 35 |
| 8 | Medicine, Research & Experimental | 30 | 4% | 0% | 27 |
| 9 | Dermatology | 19 | 2% | 0% | 13 |
| 10 | Allergy | 18 | 1% | 0% | 7 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOSTAT MED SCI | 113109 | 1% | 67% | 4 |
| 2 | PRECLIN CLIN DEV SCI | 113109 | 1% | 67% | 4 |
| 3 | PHARMACOKINET DRUG METAB | 97474 | 6% | 5% | 42 |
| 4 | MARKER LOCALIZAT ASSAYS | 95437 | 0% | 75% | 3 |
| 5 | THER EUT BIOL ONCOL PROD | 95437 | 0% | 75% | 3 |
| 6 | BIOANAL IMMUNOL | 84834 | 0% | 100% | 2 |
| 7 | BIOANALYT SCI BIOL ANALYT BIOANALYT DEV | 84834 | 0% | 100% | 2 |
| 8 | BIOL PHARMA EARLY DEV PRED PENZBERG | 84834 | 0% | 100% | 2 |
| 9 | DMPK BIOANALYT RD | 84834 | 0% | 100% | 2 |
| 10 | PHARMACOKINET DYNAM METAB PDM NBE | 84834 | 0% | 100% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOANALYSIS | 1104391 | 26% | 13% | 195 |
| 2 | AAPS JOURNAL | 158429 | 9% | 5% | 68 |
| 3 | JOURNAL OF IMMUNOLOGICAL METHODS | 21999 | 10% | 1% | 71 |
| 4 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 7945 | 6% | 0% | 46 |
| 5 | MABS | 5322 | 1% | 1% | 10 |
| 6 | BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS | 3812 | 0% | 3% | 3 |
| 7 | JOURNAL OF IMMUNOLOGY RESEARCH | 3795 | 1% | 1% | 9 |
| 8 | ANNALS OF THE RHEUMATIC DISEASES | 2673 | 3% | 0% | 24 |
| 9 | THERAPEUTIC DRUG MONITORING | 1871 | 2% | 0% | 13 |
| 10 | BIOPHARM INTERNATIONAL | 1215 | 1% | 1% | 4 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTI DRUG ANTIBODIES | 1580627 | 10% | 51% | 73 | Search ANTI+DRUG+ANTIBODIES | Search ANTI+DRUG+ANTIBODIES |
| 2 | LIGAND BINDING ASSAY | 570954 | 5% | 38% | 35 | Search LIGAND+BINDING+ASSAY | Search LIGAND+BINDING+ASSAY |
| 3 | ANTIDRUG ANTIBODIES | 374425 | 2% | 55% | 16 | Search ANTIDRUG+ANTIBODIES | Search ANTIDRUG+ANTIBODIES |
| 4 | ANTI DRUG ANTIBODY ADA | 312340 | 1% | 82% | 9 | Search ANTI+DRUG+ANTIBODY+ADA | Search ANTI+DRUG+ANTIBODY+ADA |
| 5 | IMMUNOGENICITY | 278392 | 20% | 4% | 148 | Search IMMUNOGENICITY | Search IMMUNOGENICITY |
| 6 | DRUG INTERFERENCE | 247174 | 2% | 45% | 13 | Search DRUG+INTERFERENCE | Search DRUG+INTERFERENCE |
| 7 | GYROLAB | 246785 | 1% | 73% | 8 | Search GYROLAB | Search GYROLAB |
| 8 | NAB ASSAY | 176736 | 1% | 83% | 5 | Search NAB+ASSAY | Search NAB+ASSAY |
| 9 | SERUM BASED BIOASSAY | 169668 | 1% | 100% | 4 | Search SERUM+BASED+BIOASSAY | Search SERUM+BASED+BIOASSAY |
| 10 | TARGET INTERFERENCE | 169668 | 1% | 100% | 4 | Search TARGET+INTERFERENCE | Search TARGET+INTERFERENCE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |